DKK 7.0
(1.74%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 6.98 Million DKK | -63.27% |
2022 | 15.19 Million DKK | 98.5% |
2021 | 7.65 Million DKK | 43.0% |
2020 | 5.35 Million DKK | 49.47% |
2019 | 3.58 Million DKK | 8.02% |
2018 | 3.31 Million DKK | 35.85% |
2017 | 2.44 Million DKK | -33.78% |
2016 | 3.68 Million DKK | 2.59% |
2015 | 3.59 Million DKK | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 1.07 Million DKK | -10.09% |
2024 Q1 | 1.19 Million DKK | 49.5% |
2023 FY | 5.58 Million DKK | -63.27% |
2023 Q3 | 2.61 Million DKK | 63.05% |
2023 Q1 | 1.09 Million DKK | -85.09% |
2023 Q2 | 1.6 Million DKK | 47.11% |
2023 Q4 | 802 Thousand DKK | -69.35% |
2022 Q1 | 3.19 Million DKK | 23.29% |
2022 FY | 15.19 Million DKK | 98.5% |
2022 Q4 | 7.31 Million DKK | 360.93% |
2022 Q3 | 1.58 Million DKK | -48.77% |
2022 Q2 | 3.09 Million DKK | -3.1% |
2021 Q2 | 1.81 Million DKK | -12.57% |
2021 Q1 | 2.07 Million DKK | -9.7% |
2021 FY | 7.65 Million DKK | 43.0% |
2021 Q4 | 2.59 Million DKK | 121.25% |
2021 Q3 | 1.17 Million DKK | -35.43% |
2020 Q3 | 1.85 Million DKK | 143.42% |
2020 Q1 | 445 Thousand DKK | -3.39% |
2020 Q4 | 2.29 Million DKK | 24.27% |
2020 Q2 | 760 Thousand DKK | 70.79% |
2020 FY | 5.35 Million DKK | 49.47% |
2019 Q2 | 1.46 Million DKK | 32.62% |
2019 FY | 3.58 Million DKK | 8.02% |
2019 Q4 | 460.63 Thousand DKK | -16.38% |
2019 Q3 | 550.84 Thousand DKK | -62.41% |
2019 Q1 | 1.1 Million DKK | 33.75% |
2018 Q4 | 826.2 Thousand DKK | 0.21% |
2018 Q3 | 824.49 Thousand DKK | -24.47% |
2018 Q1 | 574 Thousand DKK | 43.79% |
2018 Q2 | 1.09 Million DKK | 90.19% |
2018 FY | 3.31 Million DKK | 35.85% |
2017 Q1 | 1.2 Million DKK | 0.0% |
2017 Q3 | 456.62 Thousand DKK | 19.24% |
2017 Q2 | 382.95 Thousand DKK | -68.14% |
2017 FY | 2.44 Million DKK | -33.78% |
2017 Q4 | 399.2 Thousand DKK | -12.57% |
2016 FY | 3.68 Million DKK | 2.59% |
2015 FY | 3.59 Million DKK | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Ambu A/S | 5.39 Billion DKK | 99.87% |
ChemoMetec A/S | 407.87 Million DKK | 98.287% |
Demant A/S | 22.44 Billion DKK | 99.969% |
GN Store Nord A/S | 18.12 Billion DKK | 99.961% |
Scandinavian Medical Solutions A/S | 191.19 Million DKK | 96.346% |